Concepedia

Lyka B. Kalyandrug

LB

Statistics

Publications

3

Citations

263

H-Index

3

Active since

2004

Affiliations

Pearl River Community College(Current)

Lyka B. Kalyandrug is an author at Pearl River Community College specializing in immunotherapy, oncology, and immunology.

Top concepts

Publications per year

2004–2006

3

Publications

3

Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma

John F. DiJoseph, Maureen Dougher, Lyka B. Kalyandrug et al. · Clinical Cancer Research · 2006 · 140 citations · Full text

Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193-<b> <i>N</i> </b>-Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and Xenografts

Erwin R. Boghaert, Latha Sridharan, Douglas Armellino et al. · Clinical Cancer Research · 2004 · 64 citations · Full text

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

John F. DiJoseph, Maureen Dougher, Douglas Armellino et al. · Cancer Immunology Immunotherapy · 2006 · 59 citations · Full text

, , +9

1–3 of 3